ENLV Latest Press Releases

-- November 2, 2026 --

Enlivex Announces Favorable 12-Month Topline Data from Phase I/IIa Allocetra Trial, Demonstrating Durable Treatment Response Globe Newswire 8:00 AM

-- October 28, 2026 --

Enlivex Announces Randomization of 135 Patients in Phase 2b Trial of Allocetra in Age-Related Primary Moderate-to-Severe Knee Osteoarthritis Globe Newswire 8:00 AM

-- October 27, 2026 --

Enlivex Announces Receipt of Delisting Notice from Nasdaq; Intends to Appeal Globe Newswire 8:00 AM

-- October 22, 2026 --

Enlivex Announces 1-for-16 Reverse Share Split to be Effective October 27, 2026 Globe Newswire 5:16 PM

-- October 19, 2026 --

Enlivex Announces Cost Reduction Plan to Focus Resources on Phase 2b Trial of Allocetra in Age-Related Primary Moderate-to-Severe Knee Osteoarthritis Globe Newswire 8:17 AM

-- September 22, 2026 --

Enlivex Announces Termination of Previously-Announced Financing Payable in RAIN Tokens Globe Newswire 8:00 AM

-- July 30, 2026 --

Enlivex Treasury Portfolio Update: RAIN Trading Volume Reaches $860MM, 622% Month-Over-Month Growth in July vs June Globe Newswire 8:00 AM

-- July 29, 2026 --

Enlivex Management to Host Webinar to Discuss Capital Strategy, Rain Protocol Treasury Strategy, and Recent Clinical Milestones Globe Newswire 8:00 AM

-- July 28, 2026 --

Enlivex Announces $400,000,000 Private Placement Globe Newswire 8:00 AM

-- July 20, 2026 --

Enlivex Treasury Portfolio Update: NAV Per Ordinary Share $66.16; Total Treasury Holdings Valued at Approximately $1.1 Billion Globe Newswire 8:00 AM

-- July 13, 2026 --

Enlivex Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for Allocetra in Age-Related Knee Osteoarthritis Globe Newswire 8:00 AM

-- July 7, 2026 --

Enlivex Announces 1-for-15 Reverse Stock Split Effective July 9, 2026 Globe Newswire 8:00 AM

-- June 24, 2026 --

Enlivex Treasury Portfolio Update: Listing of the RAIN Token on Gate, One of the World's Largest Cryptocurrency Exchanges by Spot Trading Volume Globe Newswire 8:00 AM

-- June 22, 2026 --

Enlivex Treasury Portfolio Update: RAIN Holdings Valued at Approximately $1.14 Billion Globe Newswire 8:45 AM

-- June 15, 2026 --

Enlivex Announces Issuance of Australian Patent Covering the Use of Allocetra in Patients with Osteoarthritis Globe Newswire 8:00 AM

-- June 2, 2026 --

ENLIVEX TO PRESENT QUALITY LONGEVITY MODEL POWERED BY PREDICTION MARKETS TREASURY AT PROOF OF TALK 2026 Globe Newswire 8:00 AM

Market Data Delayed 15 Minutes